If one has a prognosis of death I say let that person take whatever, and try whatever they want.
3D printing is revolutionizing manufacturing already. From food to guns, the old business models are being undermined. Information is spilling out all over the place, information one can now hold in one’s hands.
It is interesting to me how wedded some people are to the idea that Obamacare is not a crony capitalist disaster. I understand why. It is the president’s signature piece of legislation. It has long been the dream of many in this country to implement nationalized healthcare. To acknowledge that what at first appeared to be an important political victory is likely anything but, is a hard pill to swallow.
If Obamacare fails it also means that Obama fails historically, and that is also very difficult.
The pharmaceutical lobby is the most influential in Washington DC according to a recent survey by APCO Worldwide.
Compounded drugs are created specifically for patients. They are tailored by pharmacists. It’s quite a large market and many patients rely heavily on compounding to avoid ingredients which they are allergic to, etc. Big pharma sees the compounding market as an opportunity and would like it for itself. As such the industry has gone to the Senate.
Another good one from the Examiner.
The Department of Justice and the pharmaceutical industry are not keen on pharmaceutical mail order. According the the DOJ the concern is that people are ordering illegal drugs through the mail from overseas pharmacies. No doubt this is true.
Can we trust what comes out of the medical journals if 97% of the advertising within these journals is bought by pharmaceutical companies? Considering that these journals determine much of the direction of healthcare research and policy, it’s a question which needs to be asked seriously. Remember Big Pharma wrote a big piece of Obamacare.
Obamacare is now the law of the land. Later this year it will reach deep into our economy. How the law will change American life we still don’t know for the most part.
One thing we do know is that many pharmaceutical companies will do very well under the Affordable Care Act. One of those companies is Barr Laboratories, maker of the “morning after pill” Plan B.